Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
| Company Details | |
|---|---|
| Title | Denali Therapeutics |
| Industries | Biotechnology, Genetics, Health Diagnostics, Therapeutics |
| Headquarters Regions | San Francisco Bay Area, West Coast, Western US |
| Headquarters Location | San Francisco, California, United States |
| No Of Employees | 251-500 |
| Operating Status | Active |
Description
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.